» Articles » PMID: 2578670

Demonstration of Inter- and Intraspecies Differences in Serotonin Binding Sites by Antibodies from an Autistic Child

Overview
Specialty Science
Date 1985 Jan 1
PMID 2578670
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Serotonin (5-HT) binding sites from bovine and rat cerebral cortex membranes share pharmacological properties that allow both to be subclassified by the same criteria. We show here that [3H]5-HT binding sites from human cortex also possess pharmacological properties that follow the same subclassification scheme as for bovine and rat cortex. In addition, we show that solubilized 5-HT1 and 5-HT3 sites from all three species have an s20,w value of 3.4. Despite these similar pharmacological and physical characteristics, we can demonstrate antigenic differences between receptor types and species. Human 5-HT1A sites can be distinguished from human 5-HT1B, 5-HT2, and 5-HT3 sites and from equivalent sites in rat and bovine cortex. The anti-human 5-HT1A antibodies were discovered in the blood of an autistic child and may have clinical or etiologic significance for this disorder.

Citing Articles

Natural IgG Anti-F (ab') Autoantibody Activity in Children with Autism.

Tordjman S, Charrier A, Kazatchkine M, Roubertoux P, Botbol M, Bronsard G Biomedicines. 2023; 11(3).

PMID: 36979694 PMC: 10045297. DOI: 10.3390/biomedicines11030715.


International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.

Barnes N, Ahern G, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S Pharmacol Rev. 2020; 73(1):310-520.

PMID: 33370241 PMC: 7770494. DOI: 10.1124/pr.118.015552.


Antigenic Targets of Patient and Maternal Autoantibodies in Autism Spectrum Disorder.

Mazon-Cabrera R, Vandormael P, Somers V Front Immunol. 2019; 10:1474.

PMID: 31379804 PMC: 6659315. DOI: 10.3389/fimmu.2019.01474.


Increased anti-phospholipid antibodies in autism spectrum disorders.

Careaga M, Hansen R, Hertz-Piccotto I, Van de Water J, Ashwood P Mediators Inflamm. 2013; 2013:935608.

PMID: 24174712 PMC: 3794552. DOI: 10.1155/2013/935608.


HLA Immune Function Genes in Autism.

Torres A, Westover J, Rosenspire A Autism Res Treat. 2012; 2012:959073.

PMID: 22928105 PMC: 3420779. DOI: 10.1155/2012/959073.


References
1.
Almon R, Andrew C, Appel S . Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors. Science. 1974; 186(4158):55-7. DOI: 10.1126/science.186.4158.55. View

2.
Ornitz E, Ritvo E . The syndrome of autism: a critical review. Am J Psychiatry. 1976; 133(6):609-21. DOI: 10.1176/ajp.133.6.609. View

3.
Fillion G, Rousselle J, Fillion M, Beaudoin D, Goiny M, Deniau J . High-affinity binding of (3H) 5-hydroxytryptamine to brain synaptosomal membranes: comparison with (3H) lysergic acid diethylamide binding. Mol Pharmacol. 1978; 14(1):50-9. View

4.
Pedigo N, Yamamura H, Nelson D . Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain. J Neurochem. 1981; 36(1):220-6. DOI: 10.1111/j.1471-4159.1981.tb02397.x. View

5.
Peroutka S, Snyder S . Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain. Brain Res. 1981; 208(2):339-47. DOI: 10.1016/0006-8993(81)90562-x. View